The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports ...

The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports linking these vaccines to immune thrombotic thrombocytopenic purpura (TTP).

Chilean health authorities have approved the emergency use of the Sinovac Biotech (CoronaVac) coronavirus vaccine on children aged six years or older, it was announced Monday. Five experts from ...

This report presents two cases of TTP occurring after the administration of the inactivated vaccine CoronaVac from Sinovac ...

A study published in the journal Frontiers of Medicine has found an association between the inactivated COVID-19 vaccine CoronaVac from Sinovac Biotech and immune thrombotic thrombocytopenic purpura ...

The prestigious Butantan Institute Monday released the results of a study carried out between February and April 2021 among 27,000 people vaccinated with CoronaVac in Serrana, São Paulo ...

The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports ...

As the global race to produce a Covid-19 vaccine continues, China appears to have made huge strides, with vaccines from two front-runners - Sinovac and Sinopharm - already making their way abroad.

"But I was taking the risk because I had to keep working." Mr Cruz got his first dose of CoronaVac in late May. But when the time came to get his second jab, he was turned away. "Nobody had a ...

He is at the forefront of CoronaVac, the Covid-19 vaccine produced by the Chinese company Sinovac and approved on January 17 th for emergency use in Brazil, after phase 3 clinical trials coordinated ...

A trader works at the New York Stock Exchange (NYSE), after Republican presidential nominee Donald Trump won the election, in New York City, U.S., November 6, 2024. REUTERS/Andrew Kelly/File Photo ...